Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome

BACKGROUND: High doses of pooled polyclonal IgG are commonly used to treat numerous autoimmune diseases. Their mode of action nevertheless remains only partially explained. At the same time, until now, no early biological marker has been able to predict their efficacy. METHODOLOGY/PRINCIPAL FINDINGS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Izumi, Parizot, Christophe, Dorgham, Karim, Demeret, Sophie, Amoura, Zahir, Bolgert, Francis, Gorochov, Guy
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362102/
https://www.ncbi.nlm.nih.gov/pubmed/18461177
http://dx.doi.org/10.1371/journal.pone.0002109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362102/
https://www.ncbi.nlm.nih.gov/pubmed/18461177
http://dx.doi.org/10.1371/journal.pone.0002109

Ejemplares similares